Paul Howard, Ph.D. is a Senior Fellow and the Director of the Manhattan Institute's Center for Medical Progress. He is the managing editor of Medical Progress Today, a web magazine devoted to chronicling the connection between private sector investment and biomedical innovation, market-friendly public policies, and improved health.
As editor, he has written on a wide variety of medical policy issues, including medical malpractice, FDA reform, and Medicare policy initiatives. He is often quoted on health care issues and his columns have appeared in newspapers across the country, including the New York Post, Dallas Morning News, Investor's Business Daily and WashingtonPost.com. He is also a member of the Manhattan Institute's Project FDA, a committee of physician-scientists, economists, medical ethicists, and policy experts. Their purpose is to show how 21st-century technologies can help better inform FDA regulations and accelerate the drug-development and drug-approval process while maintaining drug safety.
When Paul first joined the Manhattan Institute in 2000, he worked as the Deputy Director for the Center for Legal Policy where he edited research papers, managed legal policy analyses and organized conferences.
Paul Howard received his Ph.D. in political science from Fordham University in 2003, and is a graduate of the College of the Holy Cross in Worcester, Massachusetts.
No matter what the Supreme Court decides tomorrow, Congress will have to revisit Obamacare’s fundamentally flawed structure. But instead of trying to solve all of our health care woes at a single stroke, Congress should carefully examine what the most pressing shortcomings of the health care system actually are, address those with common sense reforms, and then free the states to innovate.
By loading trillions in new spending on top of existing health-care entitlements and raising the specter of far less innovation in health care as government’s role in the market grows, ObamaCare represents a serious wrong turn.